Status:
COMPLETED
Assessment of SARS-CoV-2 Seroprevalence in Detention
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
COVID-19
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
"Background France counted on January 1, 2020, 70,651 people detained, for 61,080 places. Overcrowding in detention is considered as risk factor for infectious diseases transmission, such as respirato...
Detailed Description
" 1. Scientific justification for the research o Current knowledge SARS-CoV-2, a new coronavirus infecting human, is responsible for the COVID-19 pandemic. The virus is transmitted either dir...
Eligibility Criteria
Inclusion
- Detained woman appearing on the lists supplied by the penitentiary establishments or detained man drawn by lot from the lists supplied by the penitentiary establishments.
- Age from 18 to 80 years old.
- Free and informed consent signed."
Exclusion
- Subject likely not to respect the terms of the study
- Persons who are placed under legal protection
- Person released from detention between the day of selection and the day of the planned consultation
- Person who are not attending the inclusion consultation after two invitations
- Patient who do not speaking French and are not accompanied by a translator
- Pregnant and lactating women
Key Trial Info
Start Date :
January 14 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 8 2021
Estimated Enrollment :
1044 Patients enrolled
Trial Details
Trial ID
NCT04516512
Start Date
January 14 2021
End Date
July 8 2021
Last Update
December 9 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
USMP
Le Kremlin-Bicêtre, France, 94275